M
Myron S. Cohen
Researcher at University of North Carolina at Chapel Hill
Publications - 576
Citations - 50913
Myron S. Cohen is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Population & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 103, co-authored 549 publications receiving 46021 citations. Previous affiliations of Myron S. Cohen include University of Massachusetts Medical School & Scripps Health.
Papers
More filters
Journal ArticleDOI
Differential penetration of raltegravir throughout gastrointestinal tissue: implications for eradication and cure.
Kristine B. Patterson,Heather M.A. Prince,Trenton Stevens,Nicholas J. Shaheen,Evan S. Dellon,Ryan D. Madanick,Steven H. Jennings,Myron S. Cohen,Angela D. M. Kashuba +8 more
TL;DR: The data suggest that RAL should result in full suppression of viral replication in GI tissue and GALT and remain higher than any antiretroviral investigated to date.
Journal ArticleDOI
How can we better identify early HIV infections
TL;DR: Applying optimal combinations of tests in diagnostic and HIV incidence algorithms is urgently needed to support the multiple goals derived from enhanced detection and discrimination of EHIs.
Journal ArticleDOI
Initial HIV-1 Antigen-Specific CD8+ T Cells in Acute HIV-1 Infection Inhibit Transmitted/Founder Virus Replication
Stephanie A. Freel,Ralph A. Picking,Guido Ferrari,Haitao Ding,Christina Ochsenbauer,John C. Kappes,Jennifer L. Kirchherr,Jennifer L. Kirchherr,Kelly A. Soderberg,Kelly A. Soderberg,Kent J. Weinhold,Kent J. Weinhold,Coleen K. Cunningham,Thomas N. Denny,Thomas N. Denny,John A. Crump,Myron S. Cohen,Andrew J. McMichael,Barton F. Haynes,Barton F. Haynes,Georgia D. Tomaras +20 more
TL;DR: Insight is provided into the mechanisms of CD8-mediated virus inhibition and functional analyses will be important for determining whether similar antigen-specific virus inhibition can be induced by T cell-directed vaccine strategies.
Journal ArticleDOI
Adherence to Early Antiretroviral Therapy: Results From HPTN 052, a Phase III, Multinational Randomized Trial of ART to Prevent HIV-1 Sexual Transmission in Serodiscordant Couples.
Steven A. Safren,Steven A. Safren,Kenneth H. Mayer,Kenneth H. Mayer,San San Ou,Marybeth McCauley,Beatriz Grinsztejn,Mina C. Hosseinipour,Nagalingeswaran Kumarasamy,Theresa Gamble,Irving F. Hoffman,David D. Celentano,Ying Qing Chen,Myron S. Cohen +13 more
TL;DR: Mental health was the only psychosocial variable associated with adherence, and adherence was high among individuals in stable relationships taking ART for prevention, mental health and adherence covaried.